Hookipa Sale Purchase Of Stock vs Change Receivables Analysis

HOOK Stock  USD 2.41  0.13  5.12%   
Hookipa Pharma financial indicator trend analysis is much more than just examining Hookipa Pharma latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hookipa Pharma is a good investment. Please check the relationship between Hookipa Pharma Sale Purchase Of Stock and its Change Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.

Sale Purchase Of Stock vs Change Receivables

Sale Purchase Of Stock vs Change Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hookipa Pharma Sale Purchase Of Stock account and Change Receivables. At this time, the significance of the direction appears to have no relationship.
The correlation between Hookipa Pharma's Sale Purchase Of Stock and Change Receivables is 0.09. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Change Receivables in the same time period over historical financial statements of Hookipa Pharma, assuming nothing else is changed. The correlation between historical values of Hookipa Pharma's Sale Purchase Of Stock and Change Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Hookipa Pharma are associated (or correlated) with its Change Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change Receivables has no effect on the direction of Sale Purchase Of Stock i.e., Hookipa Pharma's Sale Purchase Of Stock and Change Receivables go up and down completely randomly.

Correlation Coefficient

0.09
Relationship DirectionPositive 
Relationship StrengthInsignificant

Sale Purchase Of Stock

Change Receivables

The difference in the amount of accounts receivable from one accounting period to the next. A positive number indicates an increase in receivables, while a negative number indicates a decrease.
Most indicators from Hookipa Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hookipa Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.At this time, Hookipa Pharma's Tax Provision is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 57.8 M this year, although the value of Selling General Administrative will most likely fall to about 15.8 M.
 2021 2022 2023 2024 (projected)
Interest Expense898K687K317K565.6K
Depreciation And Amortization4.6M3.6M3.6M2.9M

Hookipa Pharma fundamental ratios Correlations

0.830.850.840.930.570.980.860.73-0.94-0.80.740.960.870.720.56-0.580.960.91-0.8-0.56-0.770.940.780.88-0.69
0.830.710.640.910.190.90.840.43-0.69-0.580.590.740.860.810.56-0.330.740.76-0.71-0.3-0.840.760.850.66-0.84
0.850.710.970.820.710.850.920.9-0.68-0.920.820.70.910.620.15-0.830.70.89-0.73-0.81-0.780.970.90.94-0.65
0.840.640.970.820.750.820.850.95-0.69-0.940.90.70.860.680.23-0.80.70.9-0.77-0.79-0.790.950.850.98-0.66
0.930.910.820.820.430.930.860.71-0.81-0.720.710.850.880.910.59-0.450.850.83-0.75-0.42-0.950.870.90.83-0.91
0.570.190.710.750.430.450.50.82-0.6-0.890.610.510.490.25-0.2-0.910.510.58-0.43-0.92-0.380.640.470.71-0.25
0.980.90.850.820.930.450.880.66-0.88-0.750.730.920.890.730.54-0.530.920.89-0.78-0.5-0.80.940.820.84-0.72
0.860.840.920.850.860.50.880.74-0.66-0.790.690.691.00.670.33-0.680.690.92-0.82-0.66-0.80.910.920.85-0.71
0.730.430.90.950.710.820.660.74-0.6-0.870.770.60.740.580.1-0.790.60.77-0.62-0.79-0.710.850.760.91-0.57
-0.94-0.69-0.68-0.69-0.81-0.6-0.88-0.66-0.60.72-0.6-0.98-0.67-0.6-0.520.51-0.98-0.750.630.480.62-0.8-0.58-0.730.56
-0.8-0.58-0.92-0.94-0.72-0.89-0.75-0.79-0.870.72-0.85-0.67-0.79-0.55-0.080.92-0.67-0.850.730.910.67-0.89-0.76-0.920.54
0.740.590.820.90.710.610.730.690.77-0.6-0.850.610.710.670.36-0.640.610.85-0.83-0.65-0.690.860.670.93-0.56
0.960.740.70.70.850.510.920.690.6-0.98-0.670.610.70.620.59-0.441.00.77-0.65-0.41-0.650.830.610.74-0.58
0.870.860.910.860.880.490.891.00.74-0.67-0.790.710.70.720.37-0.660.70.92-0.84-0.63-0.830.910.930.86-0.75
0.720.810.620.680.910.250.730.670.58-0.6-0.550.670.620.720.66-0.220.620.66-0.69-0.2-0.950.660.80.71-0.96
0.560.560.150.230.59-0.20.540.330.1-0.52-0.080.360.590.370.660.280.590.47-0.60.28-0.470.360.250.36-0.5
-0.58-0.33-0.83-0.8-0.45-0.91-0.53-0.68-0.790.510.92-0.64-0.44-0.66-0.220.28-0.44-0.680.521.00.41-0.73-0.61-0.740.27
0.960.740.70.70.850.510.920.690.6-0.98-0.670.611.00.70.620.59-0.440.77-0.65-0.41-0.650.830.610.74-0.58
0.910.760.890.90.830.580.890.920.77-0.75-0.850.850.770.920.660.47-0.680.77-0.95-0.68-0.710.950.780.94-0.6
-0.8-0.71-0.73-0.77-0.75-0.43-0.78-0.82-0.620.630.73-0.83-0.65-0.84-0.69-0.60.52-0.65-0.950.530.66-0.81-0.66-0.860.57
-0.56-0.3-0.81-0.79-0.42-0.92-0.5-0.66-0.790.480.91-0.65-0.41-0.63-0.20.281.0-0.41-0.680.530.38-0.71-0.58-0.740.24
-0.77-0.84-0.78-0.79-0.95-0.38-0.8-0.8-0.710.620.67-0.69-0.65-0.83-0.95-0.470.41-0.65-0.710.660.38-0.77-0.94-0.780.98
0.940.760.970.950.870.640.940.910.85-0.8-0.890.860.830.910.660.36-0.730.830.95-0.81-0.71-0.770.840.96-0.64
0.780.850.90.850.90.470.820.920.76-0.58-0.760.670.610.930.80.25-0.610.610.78-0.66-0.58-0.940.840.81-0.88
0.880.660.940.980.830.710.840.850.91-0.73-0.920.930.740.860.710.36-0.740.740.94-0.86-0.74-0.780.960.81-0.64
-0.69-0.84-0.65-0.66-0.91-0.25-0.72-0.71-0.570.560.54-0.56-0.58-0.75-0.96-0.50.27-0.58-0.60.570.240.98-0.64-0.88-0.64
Click cells to compare fundamentals

Hookipa Pharma Account Relationship Matchups

Hookipa Pharma fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets143.7M187.8M126.0M170.5M161.3M146.4M
Short Long Term Debt Total10.6M10.5M10.6M6.5M6.6M8.3M
Other Current Liab8.4M6.4M11.6M13.4M14.4M9.4M
Total Current Liabilities14.8M21.1M27.7M35.6M42.0M25.1M
Total Stockholder Equity117.9M156.1M89.6M102.5M89.9M87.6M
Other Liab1.9M1.9M2.7M29.1M33.4M35.1M
Net Tangible Assets117.9M156.1M89.6M102.5M117.9M66.6M
Property Plant And Equipment Net14.6M14.0M22.1M22.0M13.2M14.7M
Current Deferred Revenue3.6M4.6M6.2M16.0M14.7M8.4M
Net Debt(102.6M)(132.7M)(56.3M)(106.9M)(110.5M)(116.1M)
Retained Earnings(103.0M)(147.1M)(222.8M)(287.7M)(369.3M)(350.8M)
Accounts Payable944K8.0M8.8M5.5M12.5M6.4M
Cash113.2M143.2M66.9M113.4M117.1M104.3M
Non Current Assets Total15.7M16.3M23.9M23.3M14.2M16.2M
Non Currrent Assets Other1.1M1.9M1.4M863K1.0M1.3M
Other Assets1.1M10.1M1.8M1.3M1.00.95
Long Term Debt3.5M4.5M2.2M911K819.9K778.9K
Cash And Short Term Investments113.2M143.2M66.9M113.4M117.1M104.3M
Net Receivables9.7M20.7M21.2M22.0M19.3M16.4M
Common Stock Shares Outstanding17.9M2.6M3.3M6.6M9.5M8.3M
Long Term Debt Total3.9M4.5M2.2M911K819.9K778.9K
Liabilities And Stockholders Equity143.7M187.8M126.0M170.5M161.3M146.4M
Non Current Liabilities Total11.1M10.6M8.8M32.3M29.5M24.4M
Capital Surpluse225.6M309.3M317.1M397.3M457.0M230.1M
Other Current Assets13.3M8.1M15.0M12.7M10.7M11.1M
Other Stockholder Equity81.8M309.3M317.1M397.3M467.0M264.5M
Total Liab25.8M31.7M36.5M67.9M71.5M42.7M
Net Invested Capital122.6M160.7M94.6M105.0M91.0M91.7M
Property Plant And Equipment Gross14.6M14.0M28.5M29.8M23.0M18.5M
Total Current Assets128.0M171.5M102.1M147.2M147.1M130.2M
Accumulated Other Comprehensive Income(4.7M)(6.1M)(4.8M)(7.2M)(7.9M)(8.3M)
Non Current Liabilities Other2.2M1.4M2.6M31.4M6.0M8.0M
Net Working Capital113.3M150.4M74.5M111.6M105.1M105.0M
Property Plant Equipment14.6M14.0M16.4M18.0M20.7M13.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Hookipa Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Hookipa Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Hookipa Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Hookipa Pharma Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.67)
Revenue Per Share
4.403
Quarterly Revenue Growth
(0.52)
Return On Assets
(0.20)
Return On Equity
(0.49)
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.